To determine whether AFP from our hep mouse models of mitochondrial disease also acts in an immunosuppressive manner on human cells via the same mechanism, we repeated the experiment and found that pharmacologically blocking CCR5 ablated the ability of Sco1hep plasma to kill human PBMCs (Figure 6D). Here, CCR5 is linked to inborn mitochondrial metabolism disorder.